argenx SE | ARGX - Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
AstraZeneca USD 12.61B 225M 2026-03
Genmab DKK 977M 13M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
GRIFOLS EUR 686.84M 56.95M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Qiagen NV USD 325.27M 19.53M 2025-12
UCB EUR 3.19B 621M 2025-12